Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Ligand Pharm (LGND)

Ligand Pharm (LGND)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,270,314
  • Shares Outstanding, K 16,081
  • Annual Sales, $ 186,420 K
  • Annual Income, $ -2,990 K
  • 60-Month Beta 1.28
  • Price/Sales 12.07
  • Price/Cash Flow 29.24
  • Price/Book 3.24
Trade LGND with:

Options Overview

Details
  • Implied Volatility 73.44%
  • Historical Volatility 104.16%
  • IV Percentile 75%
  • IV Rank 26.72%
  • IV High 160.34% on 01/27/21
  • IV Low 41.75% on 12/11/20
  • Put/Call Vol Ratio 0.21
  • Today's Volume 85
  • Volume Avg (30-Day) 1,838
  • Put/Call OI Ratio 1.83
  • Today's Open Interest 7,572
  • Open Int (30-Day) 13,860

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.72
  • Number of Estimates 1
  • High Estimate 0.72
  • Low Estimate 0.72
  • Prior Year 0.62
  • Growth Rate Est. (year over year) +16.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
131.01 +10.02%
on 02/23/21
219.75 -34.41%
on 02/10/21
+1.52 (+1.07%)
since 01/22/21
3-Month
82.25 +75.25%
on 12/01/20
219.75 -34.41%
on 02/10/21
+57.63 (+66.62%)
since 11/24/20
52-Week
57.24 +151.82%
on 03/17/20
219.75 -34.41%
on 02/10/21
+44.06 (+44.02%)
since 02/24/20

Most Recent Stories

More News
Ligand Pharm Up 94.4% Since SmarTrend Uptrend Call (LGND)

SmarTrend identified an Uptrend for Ligand Pharm (NASDAQ:LGND) on December 10th, 2020 at $91.31. In approximately 2 months, Ligand Pharm has returned 94.39% as of today's recent price of $177.50.

LGND : 142.31 (+0.80%)
97.5% Return Seen to Date on SmarTrend Ligand Pharm Call (LGND)

SmarTrend identified an Uptrend for Ligand Pharm (NASDAQ:LGND) on December 10th, 2020 at $91.31. In approximately 2 months, Ligand Pharm has returned 97.55% as of today's recent price of $180.38.

LGND : 142.31 (+0.80%)
Ligand (LGND) Q4 Earnings & Sales Top, 2021 Guidance Raised

Ligand (LGND) reports better-than-expected fourth-quarter 2020 numbers. The company raises outlook for 2021.

GILD : 63.71 (+0.05%)
MRK : 75.01 (+0.63%)
AMGN : 229.47 (-1.29%)
LGND : 142.31 (+0.80%)
Ligand: 4Q Earnings Snapshot

SAN DIEGO (AP) _ Ligand Pharmaceuticals Inc. (LGND) on Wednesday reported fourth-quarter net income of $5.8 million, after reporting a loss in the same period a year earlier.

LGND : 142.31 (+0.80%)
Ligand Reports Fourth Quarter and Full Year 2020 Financial Results

--Conference Call Begins at 8:30 a.m. Eastern Time Today

LGND : 142.31 (+0.80%)
Ligand Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 3, 2021 / Ligand Pharmaceuticals, Inc. (NASDAQ:LGND) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 3,...

LGND : 142.31 (+0.80%)
Ligand Partner Travere Therapeutics Announces Achievement of Interim Proteinuria Endpoint in the Ongoing Phase 3 DUPLEX Study of Sparsentan in Focal Segmental Glomerulosclerosis

--To date in the study, sparsentan has been generally well-tolerated and has shown a safety profile comparable to irbesartan

LGND : 142.31 (+0.80%)
TVTX : 29.98 (+1.08%)
Levi & Korsinsky LLP, National Class Action Law Firm, Announces Class Action Investigation Against Robinhood and Other Brokers on Behalf of Investors in Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)

New York, New York--(Newsfile Corp. - January 28, 2021) - Levi & Korsinsky, LLP, a national securities law firm that has recovered hundreds of millions of dollars for investors, announces that it has commenced...

NOK : 3.96 (+0.25%)
LGND : 142.31 (+0.80%)
Shares of LGND Up 77.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Ligand Pharm (NASDAQ:LGND) on December 10th, 2020 at $91.31. In approximately 2 months, Ligand Pharm has returned 77.26% as of today's recent price of $161.86.

LGND : 142.31 (+0.80%)
Thinking about trading options or stock in Pfizer, Ligand Pharmaceuticals, Capital One Financial, GSX Techedu, or National Beverage?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PFE, LGND, COF, GSX, and FIZZ.

FIZZ : 49.31 (+1.90%)
LGND : 142.31 (+0.80%)
COF : 124.67 (+1.74%)
GSX : 94.66 (-2.92%)
PFE : 33.84 (-0.21%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Ligand Pharmaceuticals Incorporated discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases....

See More

Key Turning Points

3rd Resistance Point 163.19
2nd Resistance Point 154.72
1st Resistance Point 147.95
Last Price 142.31
1st Support Level 132.71
2nd Support Level 124.24
3rd Support Level 117.47

See More

52-Week High 219.75
Fibonacci 61.8% 157.67
Last Price 142.31
Fibonacci 50% 138.49
Fibonacci 38.2% 119.32
52-Week Low 57.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar